These 3 Cannabis Companies Hold Cultivation Licenses In Germany: A ~$1.8B Market Opportunity?
As Germany solidifies its position as one of Europe’s largest cannabis markets, three companies stand out as key players in domestic cultivation: Tilray Brands Inc. (NASDAQ:TLRY), Aurora Cannabis Inc. (NASDAQ:ACB) and Demecan. These companies are not only significant in terms of their cultivation capacity but also in their strategic positioning to capitalize on Germany’s growing medical cannabis market, which is projected to reach a valuation of approximately €1.7 billion ($1.86 billion) by 2025.
Tilray Brands
Tilray has been a leading force in Germany’s cannabis industry, operating through its subsidiary Aphria RX GmbH.
With its comprehensive license, Tilray is authorized to cultivate a broad spectrum of medical cannabis strains. This positions Tilray as a major supplier to the German market, where the demand for medical cannabis continues to surge. The company’s production capabilities are set to significantly contribute to the market’s supply, particularly as Germany’s demand for medical cannabis is expected to climb sharply.
Aurora Cannabis
Aurora Cannabis, another heavyweight on the German cannabis scene, has been actively cultivating cannabis at its GMP-certified facility in Leuna, Saxony-Anhalt. Aurora’s operations …